Poster Presentations: Wednesday, October 26, 2011 |

Tenascin-C Levels and CD4/CD8 Ratio in Bronchoalveolar Lavage Fluid in Patients With Sarcoidosis FREE TO VIEW

Yuji Ishimatsu, MD; Hanako Fujita, MD; Noriho Sakamoto, MD; Shota Nakashima, MD; Atsuko Hara, MD; Shintaro Hara, MD; Tomoyuki Kakugawa, MD; Shigeru Kohno, MD
Chest. 2011;140(4_MeetingAbstracts):616A. doi:10.1378/chest.1117227
Text Size: A A A
Published online


PURPOSE: Sarcoidosis is an inflammatory, granulomatous disease of unknown etiology that usually involves the lungs, but may affect any organ in the body. Tenascin-C is an extracellular matrix molecule that may modulate the adhesive and migratory functions of cells and is expressed during inflammation and wound healing in various tissues. Tenascin-C has been reported to be expressed in various respiratory diseases such as sarcoidosis, interstitial pneumonia and cryptogenic organizing pneumonia. The present study was aimed to investigate the role of tenascin-C in the pathogenesis of sarcoidoisis.

METHODS: We used enzyme-linked immunosorbent assays to measure levels of tenascin-C in serum and bronchoalveolar lavage fluid (BALF) from 37 patients with sarcoidosis and 15 healthy individuals.

RESULTS: BALF levels of tenascin-C were significantly elevated in patients with sarcoidosis compared with healthy individuals but not serum levels. The levels of tenascin-C in BALF from patients with sarcoidosis were positively correlated with the percentage of BALF lymphocytes and ratio of CD4+ to CD8+ T-lymphocytes (CD4/CD8 ratio) in BALF. In addition, BALF levels of tenascin-C were higher in the patients with chest X-ray type II and III than those with chest X-ray type 0 and I.

CONCLUSIONS: We conclude that the tenascin-C concentration in BALF is increased in patients with sarcoidosis, especially pulmonary sarcoidosis with chest X-ray type II and III, and positively correlated with the percentage of BAL lymphocytes and CD4/CD8 ratio of T-lymphocytes. These results suggest that tenascin-C in the lung might be involved in the development of granulomas and fibrosis in the lungs of patients with sarcoidosis.

CLINICAL IMPLICATIONS: Tenascin-C concentration in BALF might be one of useful biomarkers for sarcoidosis.

DISCLOSURE: The following authors have nothing to disclose: Yuji Ishimatsu, Hanako Fujita, Noriho Sakamoto, Shota Nakashima, Atsuko Hara, Shintaro Hara, Tomoyuki Kakugawa, Shigeru Kohno

No Product/Research Disclosure Information

09:00 AM - 10:00 AM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543